The 2024 Glaucoma UK/Royal College of Ophthalmologists Research Award has been granted to Dr Lisa Hill and Dr Victoria McGilligan for two projects to the total of nearly £200,000.
Dr Lisa Hill at the University of Birmingham has received £99,652 towards the development of a treatment for primary open angle glaucoma by targeting the prevention and treatment of extracellular matrix ECM dysfunction.
Dr Victoria McGilligan at Ulster University has been awarded £99,919 to develop a bispecific antibody therapy targeting the NLRP3 inflammasome for glaucoma, which is said to potentially stop glaucoma progression, offering a new treatment approach beyond just lowering eye pressure.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here
